RE: Give us an update on human trials.21 Mar 2018 14:31
Got it:
Whilst the Company awaits the imminent commencement of pilot human trials for its reformulation of sildenafil, the Directors have been developing a work plan for the Company's proprietary Nuvec� technology. Nuvec� is a nanosilica system which targets the delivery of therapeutics such as RNA, DNA, vaccines and targeted cancer therapies and is being positioned as a potential alternative delivery system to lipid nanoparticles and lipid nanosomes.